Available Until 2/23/2024

Certification in Specialty Pharmacy Exam - Preparation Course

This activity is available for $149 to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education (CSPE) 

 View more NASP/CSPE Activities

Activity Description

Specialty pharmacy is the fastest growing segment of pharmacy practice today and will continue for the foreseeable future. Specialty pharmacy impacts only a small percent of the population; however, the diseases and drug therapies are very complex and require a higher level of knowledge compared to more traditional diseases and drug therapies. The Certified Specialty Pharmacist Credential is designed to validate your professional expertise, elevate the status of the specialty pharmacy profession, differentiate yourself in a competitive job market, position yourself for handling limited or exclusively distributed drugs, position yourself to better serve payer requirements, and protect the public by improving their health outcomes and reducing medication errors.

The CSP Exam Preparatory Course will cover aspects of Clinical, Fulfillment, Intake and Outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed. Key topics include the fundamentals and considerations for the patient intake process, as well as fulfillment workflows, quality assurance and dispensing channels. Outcomes measures and standards are covered, and clinical modules review persistence and adherence, specialty drug classes, indications, interactions, and more.

Learning Objectives

The target audience for this activity includes pharmacists. At the completion of this activity, participants will be able to:

  • Review the pharmacotherapy of specialty oncology medications.
  • Review the pharmacotherapy of the specialty medications used for hemophilia and immune deficiency disorders.
  • Review the pharmacotherapy of medications used in the treatment of solid organ transplantation.
  • Discuss the pharmacotherapy of the medications used in the treatment of solid organ infertility.
  • Discuss the pharmacotherapy of the specialty medications used to treat HIV, Hepatitis C and Cystic Fibrosis.
  • Review the pharmacotherapy of the specialty medications used to treat Multiple Sclerosis and other neurological disorders.
  • Discuss the pharmacotherapy of the specialty medications used to treat Pulmonary Arterial Hypertension, Hypercholesterolemia, Growth Hormone Deficiency and RSV.
  • List the fundamental steps of the patient intake, reimbursement, fulfillment and outcomes process for specialty patients.
  • Outline the medication management processes for the specialty pharmacy.
  • Discuss the pharmacotherapy of the specialty medications used to treat inflammatory diseases (including gastrointestinal, dermatological and rheumatological disorders).
  • Describe specialty medications used in the treatment of Osteoporosis.


Emily Eastman, PharmD, MBA, CSP
Service Line Coordinator, UK Specialty Pharmacy
Assistant Adjunct Professor, UK College of Pharmacy

Brenda L. Gray, PharmD, CNSC, BCNSP, VA-BC, PRS, CVAA(c)
Owner and Senior Pharmacist Consultant, Clinical Pharmacy Partners

Selina Mullins, PharmD, MBA, MSCS, CSP
Clinical Specialty Pharmacist, Kentucky Neuroscience Institute
UK Healthcare Specialty Pharmacy

Melissa J. Nelson, PharmD, CSP
Specialty Pharmacy Manager, Fairview Pharmacy Services

Marci Saknini, PharmD
Clinical Pharmacist, Vanderbilt Rheumatology — Cool Springs
Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center

Rushabh Shah, PharmD, MBA, AAHIVP, CSP
Associate Director, University of Kentucky Specialty Pharmacy

Marcy Snell, PharmD, CSP
Coordinator of Oncology Services, Henry Ford Pharmacy Advantage

Kristen Whelchel, PharmD
Clinical Pharmacist, Vanderbilt Specialty Pharmacy


It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. The following speakers have no relevant financial and/or commercial relationships: Emily Eastman, Sellina Mullins, Melissa J. Nelson, Marci Saknini, Rushabh Shah, Marcy Snell, Kristen Whelchel. Brenda Gray provided research publication for BD Canada and is a salary consultant for accreditation prep and clinical education for Clinical Pharmacy Partners.

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

CE Accreditation

Release Date: 2-23-2021
Expiration Date: 2-23-2024


This CE activity is jointly provided by ProCE, LLC and NASP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers 0221-9999-21-076-H04-P, 0221-9999-21-077-H04-P and 0221-9999-21-078-H04-P have been assigned to these knowledge-based home-study CE activities. These activities (3 individual activities) are approved for a maximum of 8.0 total contact hours (0.8 CEU) in states that recognize ACPE providers. Completion of the evaluations and the post-tests with a score of 70% or higher are required to receive CE credit. No partial credit will be given.


No external support has been received for this activity.

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.